IFNG and neoplasm: Exposure to interferon-γ (IFNγ) during T-cell-mediated immune surveillance leads to an “immunometabolic editing”, whereby tumor cells coordinate the simultaneous activation of FASN and immune checkpoints such as programmed death ligand-1 (PD-L1) to maximize tumor proliferation and immune evasion.